PROMIS NEUROSCIENCES INC. Fair Value Adjustment of Warrants
PROMIS NEUROSCIENCES INC. (PMN) reported Fair Value Adjustment of Warrants of -$44.95 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-08-13
- PROMIS NEUROSCIENCES INC. fair value adjustment of warrants for the quarter ending 2024-06-30 was -$59.09K.
- PROMIS NEUROSCIENCES INC. fair value adjustment of warrants for the quarter ending 2024-03-31 was $14.13K, a 66.08% decline year-over-year.
- PROMIS NEUROSCIENCES INC. fair value adjustment of warrants for the quarter ending 2023-12-31 was -$183.17K.
- PROMIS NEUROSCIENCES INC. fair value adjustment of warrants for the quarter ending 2023-09-30 was -$119.02K.
- PROMIS NEUROSCIENCES INC. fair value adjustment of warrants for fiscal 2023 was -$866.74K.
- PROMIS NEUROSCIENCES INC. fair value adjustment of warrants for fiscal 2022 was -$1.56M.
- PROMIS NEUROSCIENCES INC. fair value adjustment of warrants for fiscal 2021 was -$840.55K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$59.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$44.95K 10-Q · filed 2025-08-13 | -$228.12K derived: sum of 3 quarters · filed 2025-08-13 | -$347.14K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $14.13K 10-Q · filed 2025-05-12 | -$169.04K derived: sum of 2 quarters · filed 2025-05-12 | -$288.06K derived: sum of 3 quarters · filed 2025-05-12 | -$894.27K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$183.17K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$302.19K derived: sum of 2 quarters · filed 2024-04-01 | -$908.40K derived: sum of 3 quarters · filed 2024-08-08 | -$866.74K 10-K · filed 2024-04-01 |
| 2023-09-30 | -$119.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$725.23K derived: sum of 2 quarters · filed 2024-08-08 | -$683.57K 10-Q · filed 2023-11-14 | -$1.92M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | -$606.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$564.55K 10-Q · filed 2024-08-08 | -$1.80M derived: sum of 3 quarters · filed 2024-08-08 | -$1.86M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $41.66K 10-Q · filed 2024-05-14 | -$1.19M derived: sum of 2 quarters · filed 2024-05-14 | -$1.25M derived: sum of 3 quarters · filed 2024-05-14 | -$1.28M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$1.29M derived: sum of 2 quarters · filed 2024-04-01 | -$1.32M derived: sum of 3 quarters · filed 2024-04-01 | -$1.56M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$82.18K derived: sum of 2 quarters · filed 2023-11-14 | -$326.74K 10-Q · filed 2023-11-14 | -$1.14M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$23.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$267.74K 10-Q · filed 2023-08-14 | -$1.08M derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$244.56K 10-Q · filed 2023-05-15 | -$1.05M derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$809.41K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$840.55K 10-K · filed 2023-03-08 | ||
| 2021-09-30 | -$31.14K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |